351 related articles for article (PubMed ID: 17980231)
21. Clinical perspective of antibacterial usage.
Adam D
Scand J Infect Dis Suppl; 1986; 49():196-200. PubMed ID: 3469749
[TBL] [Abstract][Full Text] [Related]
22. Emerging problems in antimicrobial resistance.
Tenover FC
J Intraven Nurs; 1995; 18(6):297-300. PubMed ID: 8699288
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of bacterial resistance to antimicrobial agents.
Stratton CW
J Med Liban; 2000; 48(4):186-98. PubMed ID: 11214188
[TBL] [Abstract][Full Text] [Related]
24. New antimicrobial agents for use in the intensive care unit.
Ritchie DJ; Alexander BT; Finnegan PM
Infect Dis Clin North Am; 2009 Sep; 23(3):665-81. PubMed ID: 19665089
[TBL] [Abstract][Full Text] [Related]
25. Methicillin resistant Staphylococcus aureus infections-implications in hospital infection control.
Krishna BV; Patil A; Chandrasekhar MR
Indian J Public Health; 2007; 51(1):43-6. PubMed ID: 18232141
[TBL] [Abstract][Full Text] [Related]
26. [Microbial spectrum in surgical infections based on a microbiological routine monitoring over the 10-year period from 1995 to 2004].
Mroczkowski P; Lauf H; Lippert H; König W; Meyer F
Zentralbl Chir; 2009 Jun; 134(3):226-30. PubMed ID: 19536716
[TBL] [Abstract][Full Text] [Related]
27. Anti-infective drugs in the prevention and treatment of sepsis syndrome.
Beam TR
Crit Care Nurs Clin North Am; 1994 Jun; 6(2):275-93. PubMed ID: 7946188
[TBL] [Abstract][Full Text] [Related]
28. Bacterial incidence and antibiotic sensitivity pattern in moderate and severe infections in hospitalised patients.
Ghosh A; Karmakar PS; Pal J; Chakraborty N; Debnath NB; Mukherjee JD
J Indian Med Assoc; 2009 Jan; 107(1):21-2, 24-5. PubMed ID: 19588683
[TBL] [Abstract][Full Text] [Related]
29. Advances in antibacterial therapy against emerging bacterial pathogens.
Pournaras S; Iosifidis E; Roilides E
Semin Hematol; 2009 Jul; 46(3):198-211. PubMed ID: 19549574
[TBL] [Abstract][Full Text] [Related]
30. Current challenges in treating MRSA: what are the options?
Ratnaraja NV; Hawkey PM
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):601-18. PubMed ID: 18847401
[TBL] [Abstract][Full Text] [Related]
31. In vitro activities of 28 antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA) from a clinical setting in Malaysia.
Neela V; Sasikumar M; Ghaznavi GR; Zamberi S; Mariana S
Southeast Asian J Trop Med Public Health; 2008 Sep; 39(5):885-92. PubMed ID: 19058585
[TBL] [Abstract][Full Text] [Related]
32. [Antifungal drug resistance: mechanisms of resistance, freqeuncy, prevention and control of resistance].
Mitrović SM; Dzamić AM; Arsić-Arsenijević VS; Radonjić IV; Kranjcić-Zec IF
Srp Arh Celok Lek; 2007; 135(7-8):486-94. PubMed ID: 17929545
[TBL] [Abstract][Full Text] [Related]
33. Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: a time-series analysis.
Aldeyab MA; Monnet DL; López-Lozano JM; Hughes CM; Scott MG; Kearney MP; Magee FA; McElnay JC
J Antimicrob Chemother; 2008 Sep; 62(3):593-600. PubMed ID: 18467307
[TBL] [Abstract][Full Text] [Related]
34. Susceptibility of Staphylococcus aureus isolated from skin and wound infections in the United States 2005-07: laboratory-based surveillance study.
Tillotson GS; Draghi DC; Sahm DF; Tomfohrde KM; Del Fabro T; Critchley IA
J Antimicrob Chemother; 2008 Jul; 62(1):109-15. PubMed ID: 18397923
[TBL] [Abstract][Full Text] [Related]
35. [Surveillance of antimicrobial resistance and antimicrobial use in a university-affiliated hospital: implementation of a computerized system].
Muller A; Patry I; Talon D; Cornette C; Lopez-Lozano JM; Plésiat P; Bertrand X
Pathol Biol (Paris); 2006 Mar; 54(2):112-7. PubMed ID: 16545634
[TBL] [Abstract][Full Text] [Related]
36. Microbial spectrum and antibiotic susceptibility profile of gram-positive aerobic bacteria isolated from cancer patients.
Ashour HM; el-Sharif A
J Clin Oncol; 2007 Dec; 25(36):5763-9. PubMed ID: 18089873
[TBL] [Abstract][Full Text] [Related]
37. Antibiotic prophylaxis in the critical care setting.
Goldman MP
Crit Care Nurs Clin North Am; 1995 Dec; 7(4):667-74. PubMed ID: 8546825
[TBL] [Abstract][Full Text] [Related]
38. [Drug resistance in the treatment of invasive fungal infections].
Nordøy I; Gaustad P
Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2607-11. PubMed ID: 19023376
[TBL] [Abstract][Full Text] [Related]
39. Clinical challenges in addressing resistance to antimicrobial drugs in the twenty-first century.
Septimus EJ; Kuper KM
Clin Pharmacol Ther; 2009 Sep; 86(3):336-9. PubMed ID: 19571803
[TBL] [Abstract][Full Text] [Related]
40. The intensive care unit in antimicrobial resistance.
Koleff MH
Postgrad Med; 2001 Feb; 109(2 Suppl):60-9. PubMed ID: 19667559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
